Devicor Medical Products completes acquisition of the HydroMARK Breast Biopsy marker portfolio

02-05-2014 Business Wire HealthComments (0)

BiotechnologyUSA

Devicor Medical Products, a portfolio company of GTCR, announced today the acquisition of the HydroMARK breast biopsy marker portfolio and related assets from Biopsy Sciences, LLC.

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top